Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 11Pain 3Breast Neoplasms 3Pain, Postoperative 2Non-melanoma Skin Cancer 2Lymphoma, Follicular 2Lung Neoplasms 2Acute Pain 2Urinary Bladder Neoplasms 1Skin Neoplasms 1Respiratory Aspiration 1Prostatic Hyperplasia 1Pneumothorax 1Pleural Neoplasms 1Pleural Effusion 1Photosensitivity Disorders 1Neurofibromatosis 1 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lower Urinary Tract Symptoms 1Hematuria 1Hand-Foot Syndrome 1Empyema, Pleural 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Diclofenac 2whole grape extract 1Vitamin E 1Tomography, Optical Coherence 1Selenium 1Negative-Pressure Wound Therapy 1Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Non-melanoma Skin Cancer × Diclofenac × Clear all
NCT02636569 2026-01-21

Topical Chemoprevention of Skin Cancer Biomarkers

University of Alabama at Birmingham

Phase 2 Completed
24 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

University of Alabama at Birmingham

Phase 2 Completed
64 enrolled
Dermatologic

Non-melanoma Skin Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡